Which has the lower trailing P/E, ADMA or PRVA?

ADMA has the lower trailing P/E: ADMA trades at 14.63 and PRVA at 94.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ADMA or PRVA?

Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus PRVA at 22.35%.

Is ADMA or PRVA more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus PRVA at 1.19%.

How have ADMA and PRVA total returns compared?

Over the past 5 years, ADMA delivered 54.74% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Privia Health Group, Inc. (PRVA)

A side-by-side comparison of ADMA Biologics, Inc. and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.37B

$10.24HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

PRVA

Privia Health Group, Inc.

$2.58B

$20.48HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

Total return — ADMA vs PRVA

growth of $100 · dividends reinvested · last 5y

ADMA +443.5% (+40.3%/yr)PRVA -11.1% (-2.3%/yr)ADMA compounded faster over this window

Log scale — wide-divergence pair

ADMA PRVA

ADMA vs PRVA: by the numbers

•PRVA is the larger company ($2.58B vs $2.37B market cap).
•ADMA trades at the lower trailing earnings multiple (14.63 vs 94.42 P/E), one valuation lens rather than an overall verdict.
•ADMA converts more revenue to profit (32.98% vs 1.19% net margin).
•ADMA grew revenue faster over the past five years (54.55% vs 22.35% CAGR).

Metrics side by side

Valuation

Metric	ADMA	PRVA
P/E ratio	14.63	94.42
Forward P/E	12.85	79.52
P/S ratio	4.63	1.09
P/B ratio	5.81	0.00
EV / EBITDA	10.80	N/A
FCF yield	4.91%	N/A

Profitability

Metric	ADMA	PRVA
Gross margin	64.71%	7.61%
Operating margin	42.26%	1.90%
Net margin	32.98%	1.19%
ROE	41.39%	0.00%
ROIC	27.60%	0.00%

Growth (annualized)

Metric	ADMA	PRVA
Revenue CAGR (5Y)	54.55%	22.35%
EPS CAGR (5Y)	N/A	-8.73%
Total return CAGR (5Y)	54.74%	-1.30%

Frequently asked

Which has the lower trailing P/E, ADMA or PRVA?: ADMA has the lower trailing P/E: ADMA trades at 14.63 and PRVA at 94.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ADMA or PRVA?: Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus PRVA at 22.35%.
Is ADMA or PRVA more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus PRVA at 1.19%.
How have ADMA and PRVA total returns compared?: Over the past 5 years, ADMA delivered 54.74% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full PRVA analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio Privia Health P/E ratio ADMA Biologics ROE Privia Health ROE ADMA Biologics operating margin Privia Health operating margin ADMA Biologics revenue growth Privia Health revenue growth ADMA Biologics free cash flow Privia Health free cash flow

ADMA Biologics & Privia Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.